These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 4034851)

  • 1. Diagnostic performance of the thirty-four hour dexamethasone suppression test.
    Ansseau M; Doumont A; Cerfontaine JL; Sulon J; Demey-Ponsart E; Geenen V; Legros JJ
    Psychoneuroendocrinology; 1985; 10(2):215-9. PubMed ID: 4034851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance of basal free cortisol/18-hydroxy-11-deoxycorticosterone (18-OH-DOC) ratio in endogenous depression: comparison with the dexamethasone suppression test.
    Demey-Ponsart E; Ansseau M; Sulon J; von Frenckell R; Cerfontaine JL; Papart P; Franck G; Geenen V; Legros JJ
    Biol Psychiatry; 1987 Aug; 22(8):947-56. PubMed ID: 3607136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thirty-four hour dexamethasone suppression test in depression.
    Faber R
    Psychoneuroendocrinology; 1983; 8(4):463-6. PubMed ID: 6675038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The dexamethasone suppression test in patients with mood disorders.
    Rush AJ; Giles DE; Schlesser MA; Orsulak PJ; Parker CR; Weissenburger JE; Crowley GT; Khatami M; Vasavada N
    J Clin Psychiatry; 1996 Oct; 57(10):470-84. PubMed ID: 8909334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of saliva cortisol in the dexamethasone suppression test.
    Ansseau M; Sulon J; Doumont A; Cerfontaine JL; Legros JJ; Sodoyez JC; Demey-Ponsart E
    Psychiatry Res; 1984 Nov; 13(3):203-11. PubMed ID: 6597459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression index: enhancement of DST diagnostic utility for depression by expressing serum cortisol as a function of serum dexamethasone.
    Arana GW; Reichlin S; Workman R; Haaser R; Shader RI
    Am J Psychiatry; 1988 Jun; 145(6):707-11. PubMed ID: 3369557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mean 14.00-17.00 h plasma cortisol concentration and its relationship to the 1 mg-dexamethasone suppression response in depressives and controls.
    Holsboer F; Gerken A; Steiger A; Fass V
    Acta Psychiatr Scand; 1984 May; 69(5):383-90. PubMed ID: 6730994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cortisol suppression and circadian rhythm in endogenous depression: a preliminary report.
    Lee MA; Taylor MA
    Biol Psychiatry; 1983 Oct; 18(10):1127-32. PubMed ID: 6652153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Results of the 8 a.m. dexamethasone suppression test constitute a suitable tool for confirming the diagnosis of melancholia. A test unaffected by the variations in the bioavailability of dexamethasone.
    Maes M; Vandewoude M; Schotte C; Cosyns P
    Neuropsychobiology; 1989; 22(1):26-32. PubMed ID: 2639285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathological correlates of plasma cortisol after dexamethasone suppression: a polydiagnostic approach.
    Philipp M; Maier W; Holsboer F
    Psychoneuroendocrinology; 1986; 11(4):499-507. PubMed ID: 3562743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test.
    Beck-Friis J; Ljunggren JG; Thorén M; von Rosen D; Kjellman BF; Wetterberg L
    Psychoneuroendocrinology; 1985; 10(2):173-86. PubMed ID: 2994141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-5-hydroxytryptophan stimulated cortisol escape from dexamethasone suppression in melancholic patients.
    Maes M; D'Hondt P; Martin M; Claes M; Schotte C; Vandewoude M; Blockx P
    Acta Psychiatr Scand; 1991 Apr; 83(4):302-6. PubMed ID: 2028807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in adolescent psychiatric inpatients.
    Targum SD; Capodanno AE
    Am J Psychiatry; 1983 May; 140(5):589-91. PubMed ID: 6846588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroendocrine aspects of primary endogenous depression: XII. Receiver operating characteristic and kappa analyses of serum and urine cortisol measures in patients and matched controls.
    Thompson LM; Rubin RT; McCracken JT
    Psychoneuroendocrinology; 1992 Oct; 17(5):507-15. PubMed ID: 1484917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The dexamethasone suppression test: its relationship to diagnoses, severity of depression and response to treatment.
    Dratcu L; Calil HM
    Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(1-2):99-117. PubMed ID: 2748868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone suppression test: use of two different dexamethasone doses.
    Hwang S; Zander J; Garvey M
    J Clin Psychiatry; 1984 Sep; 45(9):390-2. PubMed ID: 6469924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three tests of cortisol secretion in adult endogenous depressives.
    Sachar EJ; Puig-Antich J; Ryan ND; Asnis GM; Rabinovich H; Davies M; Halpern FS
    Acta Psychiatr Scand; 1985 Jan; 71(1):1-8. PubMed ID: 3969837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cortisol suppression per nanogram per milliliter of plasma dexamethasone in depressive and normal subjects.
    Carson SW; Halbreich U; Yeh CM; Asnis G; Goldstein S
    Biol Psychiatry; 1988 Sep; 24(5):569-77. PubMed ID: 3167145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of depression in a general hospital: utility and limitations of the dexamethasone suppression test.
    Thase ME; Brent DA; Neil JF; Horn TL
    Gen Hosp Psychiatry; 1985 Jan; 7(1):43-8. PubMed ID: 3967824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.